SFDA-2023-0077-V277
Major variation for application SFDA-2023-0077. Major variation: Facility Change for Neuravastatin — critical change
Variation Number
SFDA-2023-0077-V277
Type
Major
Application
Change
Status
Draft
Fee
€70,694
Submitted
—
Approved
—
Description
Major variation: Facility Change for Neuravastatin — critical change